PETS PetMed Express, Inc.
XNAS
2.90
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $1.15 – $4.10
- YTD
- -12.12%
- Straddle Price
- $3.58
- P/C Vol Ratio
- 0.00
- Market Cap
- $0.0B
- Open
- $1.21
- Day Range
- $1.18 – $1.21
- Volume
- 62,711
- Prev Close
- $1.20
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 0.92 |
| Cost of Equity (CAPM) | 9.77% (VRP-adj) |
| WACC | 9.79% |
| Volatility Risk Premium | +462.5pp (IV − HV30) |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 5 years explicit + fade |
| Free Cash Flow (TTM) | $-0.0B |
| Return on Equity (TTM) | -127.4% |
| Book / Price | 116.4% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 29.2% |
| FCF Margin (TTM) | -15.5% |
| Debt / Equity | 0.00 |
| Quality Score | 1/6 — cyclical/struggling (5y DCF) |
| SMA 50 | $1.58 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $1.31 |
| Bollinger Width / SMA20 | 2522.2% (drives anchor stability) |
| Net Debt | $-0.0B |
| Market Cap | $0B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 16.9× · 7 peers |
| Peer EV/EBITDA | n/a | 0% | median 10.0× · 7 peers |
| Peer P/B | $9.03 | 16% | median 6.5× · 7 peers |
| Peer P/S | $9.34 | 16% | median 1.1× · 7 peers |
| Market Anchor (SMA50) | $1.58 | 69% | stability 85% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
- Industry (SIC)
- RETAIL-DRUG STORES AND PROPRIETARY STORES (5912) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 189
- List Date
- 1997-09-17
- CIK
- 0001040130
- Headquarters
- Delray Beach, FL
- Homepage
- https://www.petmeds.com
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillme…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 16.32% | -1.60% | 20.40% | -18.07% | 2.59% | -3.33% | 2.72% |
| Feb | -0.46% | 7.03% | -12.41% | -19.68% | -8.11% | -10.75% | -7.40% |
| Mar | 2.61% | -3.04% | -13.02% | -4.39% | -0.71% | -16.48% | -5.84% |
| Apr | -13.46% | -16.19% | -7.19% | -15.60% | -16.54% | -5.08% | -12.34% |
| May | -1.97% | 1.66% | -2.56% | 7.58% | 6.32% | -5.65% | 0.90% |
| Jun | 9.53% | -8.13% | -10.74% | -4.93% | -13.09% | -11.52% | -6.48% |
| Jul | -7.68% | 11.10% | 6.55% | -6.19% | -4.59% | -1.52% | -0.39% |
| Aug | -7.18% | -8.01% | -18.27% | -16.27% | -5.25% | -4.55% | -9.92% |
| Sep | -3.38% | -6.15% | -11.33% | 14.29% | -16.89% | -24.59% | -8.01% |
| Oct | 6.68% | 10.75% | -37.59% | 10.81% | 4.90% | -13.14%* | -2.93% |
| Nov | -6.17% | -9.59% | -1.00% | 10.50% | -28.28% | -- | -6.91% |
| Dec | -7.03% | -8.43% | 1.20% | 5.47% | 83.91% | -- | 15.02% |
| Total | -14.94% | -29.71% | -64.25% | -37.04% | -24.96% | -64.84% | -39.29% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
BULLISH (Confidence level: 7/10)
Key drivers:
- Recent positive news headlines, particularly the announcement of Cardone Ventures' full buyout of PetMed Express, Inc.
- Technical signals indicating a potential breakout from the current range-bound trading pattern
Primary risks:
- High volatility, reflected in beta and historical volatility metrics
- Potential negative impact from earnings misses or accounting rule violations
Investment thesis: PetMed Express, Inc. (PETS) has the potential to break out of its recent range-bound trading pattern, driven by positive news and technical signals. However, the stock's high volatility and risk profile must be carefully considered.
Recent news sentiment impact: The recent positive headlines have had a significant impact on the stock price, with PETS gaining over 10% in the past week. The market narrative is focused on the potential for a breakout above the current range.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): NEUTRAL
- Medium-term (1-3 months): BEARISH
- Long-term (3-12 months): BULLISH
Support/Resistance Levels: The stock is currently trading around $1.72, with resistance at the upper Bollinger Band ($1.98) and support at the lower Bollinger Band ($1.66).
Momentum Signals:
- RSI: 35.44 (neutral)
- MACD signal: bearish
- Bollinger Bands position: neutral
Volume Analysis: The volume trends are indicating a potential breakout, with an increase in trading activity and a higher volume rate of change.
News & Sentiment Analysis
Recent Headlines Summary: The past 10 news articles have been primarily positive, with announcements of the Cardone Ventures' buyout and the holiday collection. However, there were also some negative headlines related to earnings delays and accounting rule violations.
Sentiment Assessment: The overall sentiment is POSITIVE, driven by the recent news and technical signals.
Catalyst Identification: The upcoming earnings release on June 2, 2026, could be a catalyst for the stock's price movement. The market will be watching for any surprises or guidance that may impact the company's future performance.
Market Narrative: The market narrative is focused on the potential for a breakout above the current range, driven by positive news and technical signals.
Risk & Volatility Assessment
Risk Metrics:
- Beta: 1.35 (vs SPY) - indicating high risk
- Alpha: -0.33 - indicating underperformance relative to the market
- Correlation: 0.18 - indicating low correlation with the broader market
- Stock Volatility: 0.97 - indicating high volatility
Options Market Signals: The options market is pricing in a potential move of $2.30 by expiration, driven by the recent news and technical signals.
Downside Protection: Support levels are present at the lower Bollinger Band ($1.66) and the SMA 200 ($2.37), providing some downside protection.
Market Context & Positioning
Sector Performance: The pet industry sector has been relatively strong in recent months, with many stocks outperforming the broader market.
Institutional Activity: There is an increase in institutional interest in PETS, with a higher volume of shares traded and a growing open interest in options contracts.
Correlation Analysis: The stock's price movement is not strongly correlated with the broader market, indicating a potential trading opportunity for those willing to take on more risk.
Relative Valuation: PETS is currently trading within its historical range, with some upward momentum. The relative valuation is neutral, indicating that the stock is neither significantly undervalued nor overvalued.
Key Levels & Action Items
Critical Price Levels:
- Support: $1.66 (lower Bollinger Band) and SMA 200 ($2.37)
- Resistance: $1.98 (upper Bollinger Band)
Breakout/Breakdown Levels: The stock will need to break above the upper Bollinger Band ($1.98) or below the lower Bollinger Band ($1.66) to confirm a significant price movement.
Time-Sensitive Catalysts:
- Earnings release on June 2, 2026 - potential catalyst for the stock's price movement
Risk Management: Stop-loss levels should be set around $1.50 (10% below current price), with position sizing considerations taken into account based on individual risk tolerance.
Conclusion PetMed Express, Inc. (PETS) has the potential to break out of its recent range-bound trading pattern, driven by positive news and technical signals. However, the stock's high volatility and risk profile must be carefully considered. A bullish case can be made for the stock, but investors should be prepared for potential losses and take a disciplined approach to managing their positions.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-01-20 | After-Close | 10.85% | 1.65% | 0.15x | Within |
| 2021-05-05 | After-Close | 7.02% | 0.59% | 0.08x | Within |
| 2021-07-27 | After-Close | 11.43% | 3.43% | 0.30x | Within |
| 2021-10-27 | After-Close | 9.48% | 6.90% | 0.73x | Within |
| 2022-01-25 | After-Close | 11.73% | 1.63% | 0.14x | Within |
| 2022-05-10 | After-Close | 9.45% | 4.46% | 0.47x | Within |
| 2022-07-26 | After-Close | 10.03% | 0.00% | 0.00x | Within |
| 2022-11-07 | After-Close | 11.46% | 6.55% | 0.57x | Within |
| 2023-02-06 | After-Close | 12.34% | 4.34% | 0.35x | Within |
| 2023-05-22 | After-Close | 13.04% | 3.43% | 0.26x | Within |
| 2023-07-31 | After-Close | 12.76% | 5.87% | 0.46x | Within |
| 2023-10-30 | After-Close | 20.48% | 24.95% | 1.22x | Exceeded |
| 2024-02-08 | After-Close | 24.36% | 1.87% | 0.08x | Within |
| 2024-04-15 | After-Close | 23.36% | 1.46% | 0.06x | Within |
| 2024-06-11 | After-Close | 26.01% | 11.46% | 0.44x | Within |
| 2024-08-06 | After-Close | 33.88% | 14.36% | 0.42x | Within |
| 2024-11-06 | After-Close | 23.70% | 35.78% | 1.51x | Exceeded |
| 2025-02-10 | After-Close | 19.92% | 14.04% | 0.70x | Within |
| 2025-06-16 | After-Close | 30.56% | 3.06% | 0.10x | Within |
| 2025-10-14 | After-Close | 394.53% | 0.39% | 0.00x | Within |
| 2026-06-02 | Pre-Market | 25.35% | 1.84% | 0.07x | Within |
| 2026-08-13 | After-Close | 32.02% | 10.10% | 0.32x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
PETS Options Activity & IV Rank
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 73rd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $2.2M | #1914 of 3138 | -4.6% | 13F | |
| Citadel Hedge fund Ken Griffin | $142K | #5633 of 6285 | -15.7% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PETS Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | TUDOR INVESTMENT CORP ET AL | $29.57K | 49.36% | 2026-06-30 |
| 2 | GROUP ONE TRADING LLC Custodian | $25.54K | 42.63% | 2026-06-30 |
| 3 | Simplex Trading, LLC Custodian | $4.80K | 8.01% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|
PETS Insider Trading (Form 4)
Latest: 2026-09-29| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Jeffrey Allen Willard | CEO and President | Award (A) | +250,000 | — | EDGAR | |
| 2026-09-21 | Tamar Elkeles | Director | Award (A) | +49,923 | — | EDGAR | |
| 2026-08-13 | Leslie C.G. Campbell | Interim CEO and President | Award (A) | +60,000 | — | EDGAR | |
| 2026-08-12 | Peter Batushansky | Director | Award (A) | +55,555 | — | EDGAR | |
| 2026-08-12 | James LaCamp | Director | Award (A) | +55,555 | — | EDGAR | |
| 2026-08-12 | Justin L. Mennen | Director | Award (A) | +55,555 | — | EDGAR | |
| 2026-07-24 | Douglas Krulik | CAO and Interim CFO | Award (A) | +32,500 | — | EDGAR | |
| 2026-06-26 | Douglas Krulik | CAO and Interim CFO | Award (A) | +32,500 | — | EDGAR | |
| 2026-06-09 | NINA CAPITAL HOLDINGS INC. | 10%+ Owner | Buy (P) | +75,000 | $1.75 | $131.2K | EDGAR |
| 2026-01-23 | Gian Fulgoni | Director | Disp (D) | −26,057 | — | EDGAR | |
| 2025-11-14 | Gian Fulgoni | Director | Award (A) | +33,846 | — | EDGAR | |
| 2025-11-03 | Peter Batushansky | Director | Award (A) | +33,846 | — | EDGAR | |
| 2025-11-03 | Douglas Krulik | CAO and Interim CFO | Award (A) | +20,000 | — | EDGAR | |
| 2025-11-03 | James LaCamp | Director | Award (A) | +34,866 | — | EDGAR | |
| 2025-11-03 | Leah Solivan | Director | Award (A) | +33,846 | — | EDGAR |
PETS Insider Holdings
15 insiders · @ $1.19| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | NINA CAPITAL HOLDINGS INC. | 10%+ Owner | 2,600,000 | $3.09M | $2.14M | 4 | 2026-06-09 |
| 2 | Silvercape Investments Ltd | 10%+ Owner | 2,579,696 | $3.07M | $896.7K | 7 | 2025-08-14 |
| 3 | Galante Moises Tache | 10%+ Owner | 2,575,000 | $3.06M | $2.92M | 6 | 2025-07-22 |
| 4 | Zyman Stephannie Matz | 10%+ Owner | 2,550,000 | $3.03M | $1.81M | 3 | 2025-06-04 |
| 5 | Sandra Yvette Campos | CEO & President | 578,524 | $688.4K | -$200.1K | 4 | 2025-05-02 |
| 6 | Jeffrey Allen Willard | CEO and President | 250,000 | $297.5K | $0 | 1 | 2026-09-29 |
| 7 | Leslie C.G. Campbell | Interim CEO and President | 175,000 | $208.2K | $324.6K | 9 | 2026-08-13 |
| 8 | Gian Fulgoni | Director | 132,299 | $157.4K | -$2.39M | 35 | 2026-01-23 |
| 9 | Douglas Krulik | CAO and Interim CFO | 102,500 | $122.0K | $0 | 5 | 2026-07-24 |
| 10 | Justin L. Mennen | Director | 98,274 | $116.9K | $0 | 4 | 2026-08-12 |
PETS Board & Officers
As of SEC filings through Sep 29, 2026Directors 7
- Leslie C.G. Campbell · since Jul 27, 2018
- Sandra Yvette Campos · since May 17, 2023
- Justin L. Mennen · since Jun 3, 2024
- Peter Batushansky · since Apr 9, 2025
- James LaCamp · since Oct 19, 2025
- Tamar Elkeles · since Sep 17, 2026
- Jeffrey Allen Willard · since Sep 28, 2026
Officers 2
- Jeffrey Allen Willard · CEO and President · since Sep 28, 2026
- Douglas Krulik · CAO and Interim CFO · listed since Nov 2025
10% owners 4
- Galante Moises Tache · since Sep 9, 2024
- Nina Capital Holdings Inc. (entity) · since Sep 9, 2024
- Silvercape Investments Ltd (entity) · since Mar 27, 2025
- Zyman Stephannie Matz · since Sep 9, 2024
Changes in the last 10 years (33)
| Sep 28, 2026 | Jeffrey Allen Willard became a director |
| Sep 28, 2026 | Jeffrey Allen Willard became CEO and President |
| Sep 17, 2026 | Tamar Elkeles became a director |
| Aug 13, 2026 | Leslie C.G. Campbell first listed as Interim CEO and President in an SEC filing |
| Jun 23, 2026 | The company announced the departure of Leah Solivan from the board in an SEC filing |
| Jan 23, 2026 | Gian Fulgoni reported in an SEC filing no longer being a director |
| Nov 3, 2025 | Douglas Krulik listed as CAO and Interim CFO (previously Chief Accounting Officer) in SEC filings |
| Oct 19, 2025 | James LaCamp became a director |
| Aug 11, 2025 | The company announced the departure of Sandra Yvette Campos as CEO & President in an SEC filing |
| Jul 24, 2025 | The company announced the departure of Diana G Purcel from the board in an SEC filing |
| Apr 9, 2025 | Peter Batushansky became a director |
| Mar 27, 2025 | Silvercape Investments Ltd became a 10% owner |
| Sep 26, 2024 | Robyn M. D'Elia became Chief Financial Officer |
| Sep 9, 2024 | Zyman Stephannie Matz became a 10% owner |
| Sep 9, 2024 | Nina Capital Holdings Inc. became a 10% owner |
| Sep 9, 2024 | Galante Moises Tache became a 10% owner |
| Aug 19, 2024 | Douglas Krulik became Chief Accounting Officer |
| Jun 24, 2024 | Leah Solivan became a director |
| Jun 3, 2024 | Justin L. Mennen became a director |
| May 1, 2024 | Sandra Yvette Campos first listed as CEO & President in an SEC filing |
| May 1, 2024 | Mathew N Hulett reported in an SEC filing no longer being a director |
| May 1, 2024 | Mathew N Hulett reported in an SEC filing no longer being CEO & President |
| May 17, 2023 | Sandra Yvette Campos became a director |
| May 16, 2023 | The company announced the departure of Jodi Watson from the board in an SEC filing |
| Aug 3, 2022 | Christine Chambers became CFO |
| Apr 4, 2022 | Diana G Purcel became a director |
| Mar 28, 2022 | The company announced the departure of Ronald J Korn from the board in an SEC filing |
| Aug 30, 2021 | Mathew N Hulett became a director |
| Aug 30, 2021 | Mathew N Hulett became CEO & President |
| Jul 30, 2021 | Peter Cobb became a director |
| May 25, 2021 | Jodi Watson became a director |
| Jan 28, 2021 | Bruce S Rosenbloom listed as CFO & Treasurer (previously Chief Financial Officer) in SEC filings |
| Jul 27, 2018 | Leslie C.G. Campbell became a director |
- Prev
- 1
Not reported recently (7)
- Robyn M. D'Elia · Last reported as Chief Financial Officer in an SEC filing dated Sep 27, 2024
- Christine Chambers · Last reported as CFO in an SEC filing dated Jun 4, 2024
- Peter Cobb · Last reported as a director in an SEC filing dated Aug 1, 2022
- Bruce S Rosenbloom · Last reported as CFO & Treasurer in an SEC filing dated Aug 4, 2021
- Frank J Formica · Last reported as a director in an SEC filing dated Jan 29, 2021
- Menderes Akdag · Last reported as a director in an SEC filing dated Jan 28, 2021
- Robert C Schweitzer · Last reported as a director in an SEC filing dated Aug 31, 2020
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXUS Vanguard Total International Stock ETF | Vanguard | 0.00% | $18.7M | — | 2026-09-30 |
| 2 | VEA Vanguard FTSE Developed Markets ETF | Vanguard | 0.00% | $12.5M | — | 2026-09-30 |
| 3 | IEFA iShares Core MSCI EAFE ETF | iShares (BlackRock) | 0.01% | $10.8M | $191.0B | 2026-10-20 |
| 4 | SCZ iShares MSCI EAFE Small-Cap ETF | iShares (BlackRock) | 0.04% | $4.9M | $12.9B | 2026-10-20 |
| 5 | VSS Vanguard FTSE All-World EX-US Small-Cap Index Fund | Vanguard | 0.03% | $4.7M | — | 2026-09-30 |
| 6 | VGK Vanguard FTSE Europe ETF | Vanguard | 0.01% | $3.0M | — | 2026-09-30 |
| 7 | IXUS iShares Core MSCI Total International Stock ETF | iShares (BlackRock) | 0.00% | $2.2M | $58.1B | 2026-10-20 |
| 8 | IDEV iShares Core MSCI International Developed Markets ETF | iShares (BlackRock) | 0.01% | $1.9M | $34.0B | 2026-10-20 |
| 9 | PAWZ ProShares Pet Care ETF | ProShares | 4.74% | $1.6M | — | 2026-10-21 |
| 10 | IEUR iShares Core MSCI Europe ETF | iShares (BlackRock) | 0.01% | $982,284 | $9.5B | 2026-10-20 |
| 11 | VT Vanguard Total World Stock ETF | Vanguard | 0.00% | $981,065 | — | 2026-09-30 |
| 12 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $831,857 | — | 2026-09-30 |
| 13 | ISCF iShares International Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.10% | $737,825 | $708.5M | 2026-10-20 |
| 14 | ISVL iShares International Developed Small Cap Value Factor ETF | iShares (BlackRock) | 0.20% | $662,244 | $327.6M | 2026-10-20 |
| 15 | GWX State Street® SPDR® S&P® International Small Cap ETF | SPDR (State Street) | 0.07% | $631,173 | $899.5M | 2026-10-20 |
| 16 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $291,301 | — | 2026-09-30 |
| 17 | VSGX Vanguard ESG International Stock ETF | Vanguard | 0.00% | $258,019 | — | 2026-10-20 |
| 18 | FSCC Federated Hermes MDT Small Cap Core ETF | Nport | 0.06% | $164,623 | — | 2026-05-31 |
| 19 | BSVO EA Bridgeway Omni Small-Cap Value ETF | Nport | 0.01% | $158,108 | — | 2026-06-30 |
| 20 | IEUS iShares MSCI Europe Small-Cap ETF | iShares (BlackRock) | 0.08% | $138,581 | $166.1M | 2026-10-20 |
| 21 | EWUS iShares MSCI United Kingdom Small-Cap ETF | iShares (BlackRock) | 0.29% | $115,596 | $40.0M | 2026-10-20 |
| 22 | WSML iShares MSCI World Small-Cap ETF | iShares (BlackRock) | 0.01% | $84,182 | $661.0M | 2026-10-20 |
| 23 | SPEU State Street® SPDR® Portfolio Europe ETF | SPDR (State Street) | 0.01% | $67,036 | $700.5M | 2026-10-20 |
| 24 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.00% | $56,574 | $1.2B | 2026-10-20 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q4 '26 | 2026-03-31 | $42.82M | $-4.06M | $-0.19 | $-4.74M |
| Q3 '26 | 2025-12-31 | $40.66M | $-10.55M | $-0.50 | $-9.21M |
| Q2 '26 | 2025-09-30 | $44.36M | $-8.52M | $-0.41 | $-2.17M |
| Q1 '26 | 2025-06-30 | $51.18M | $-34.15M | $-1.65 | $-12.27M |
| Q4 '25 | 2025-03-31 | $50.76M | $-11.64M | $-0.56 | $7.01M |
| Q3 '25 | 2024-12-31 | $51.96M | $-707.00K | $-0.03 | $-1.17M |
| Q2 '25 | 2024-09-30 | $58.04M | $2.33M | $0.11 | $7.39M |
| Q1 '25 | 2024-06-30 | $66.21M | $3.75M | $0.18 | $-8.52M |
| Q4 '24 | 2024-03-31 | $59.53M | $-5.02M | $-0.25 | $7.13M |
| Q3 '24 | 2023-12-31 | $65.32M | $-2.03M | $-0.10 | $-2.59M |
| Q2 '24 | 2023-09-30 | $71.00M | $715.00K | $0.03 | $-777.00K |
| Q1 '24 | 2023-06-30 | $78.24M | $-1.14M | $-0.06 | $562.00K |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.